Seguir
Daniela Pende
Daniela Pende
Ospedale Policlinico San Martino
Dirección de correo verificada de hsanmartino.it
Título
Citado por
Citado por
Año
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
A Moretta, C Bottino, M Vitale, D Pende, C Cantoni, MC Mingari, ...
Annual review of immunology 19 (1), 197-223, 2001
21832001
Receptors for HLA class-I molecules in human natural killer cells
A Moretta, C Bottino, M Vitale, D Pende, R Biassoni, MC Mingari, ...
Annual review of immunology 14 (1), 619-648, 1996
10581996
Identification of PVR (CD155) and Nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule
C Bottino, R Castriconi, D Pende, P Rivera, M Nanni, B Carnemolla, ...
The Journal of experimental medicine 198 (4), 557-567, 2003
10532003
Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
D Pende, S Parolini, A Pessino, S Sivori, R Augugliaro, L Morelli, ...
The Journal of experimental medicine 190 (10), 1505-1516, 1999
10331999
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.
L Ruggeri, A Mancusi, M Capanni, E Urbani, A Carotti, T Aloisi, M Stern, ...
Blood, The Journal of the American Society of Hematology 110 (1), 433-440, 2007
7602007
Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to …
D Pende, P Rivera, S Marcenaro, CC Chang, R Biassoni, R Conte, ...
Cancer research 62 (21), 6178-6186, 2002
6902002
Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia
RT Costello, S Sivori, E Marcenaro, M Lafage-Pochitaloff, ...
Blood, The Journal of the American Society of Hematology 99 (10), 3661-3667, 2002
5912002
Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells.
A Moretta, S Sivori, M Vitale, D Pende, L Morelli, R Augugliaro, C Bottino, ...
The Journal of experimental medicine 182 (3), 875-884, 1995
5471995
NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural …
S Sivori, D Pende, C Bottino, E Marcenaro, A Pessino, R Biassoni, ...
European journal of immunology 29 (5), 1656-1666, 1999
5391999
Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset …
A Moretta, C Bottino, D Pende, G Tripodi, G Tambussi, O Viale, A Orengo, ...
The journal of experimental medicine 172 (6), 1589-1598, 1990
4991990
NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor
M Vitale, MD Chiesa, S Carlomagno, D Pende, M Arico, L Moretta, ...
Blood 106 (2), 566-571, 2005
4842005
HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders
A Bertaina, P Merli, S Rutella, D Pagliara, ME Bernardo, R Masetti, ...
Blood, The Journal of the American Society of Hematology 124 (5), 822-826, 2014
4812014
Analysis of the receptor-ligand interactions in the natural killer–mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the …
D Pende, GM Spaggiari, S Marcenaro, S Martini, P Rivera, A Capobianco, ...
Blood 105 (5), 2066-2073, 2005
4602005
Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
D Pende, C Cantoni, P Rivera, M Vitale, R Castriconi, S Marcenaro, ...
European journal of immunology 31 (4), 1076-1086, 2001
4542001
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and …
D Pende, S Marcenaro, M Falco, S Martini, ME Bernardo, D Montagna, ...
Blood, The Journal of the American Society of Hematology 113 (13), 3119-3129, 2009
4432009
HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells
E Carbone, P Neri, M Mesuraca, MT Fulciniti, T Otsuki, D Pende, V Groh, ...
Blood 105 (1), 251-258, 2005
4162005
The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like …
D Pende, R Biassoni, C Cantoni, S Verdiani, M Falco, C Di Donato, ...
The Journal of experimental medicine 184 (2), 505-518, 1996
4121996
Human natural killer cell receptors and co‐receptors
R Biassoni, C Cantoni, D Pende, S Sivori, S Parolini, M Vitale, C Bottino, ...
Immunological reviews 181 (1), 203-214, 2001
4092001
NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo
T Lakshmikanth, S Burke, TH Ali, S Kimpfler, F Ursini, L Ruggeri, ...
The Journal of clinical investigation 119 (5), 1251-1263, 2009
4052009
Major histocompatibility complex class I‐specific receptors on human natural killer and T lymphocytes
A Moretta, R Biassoni, C Bottino, D Pende, M Vitale, A Poggi, MC Mingari, ...
Immunological reviews 155 (1), 105-117, 1997
3961997
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20